Peter L. Myers

1.9k total citations
65 papers, 1.4k citations indexed

About

Peter L. Myers is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Peter L. Myers has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Peter L. Myers's work include Chemical Synthesis and Analysis (8 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical and Molecular Research (5 papers). Peter L. Myers is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical and Molecular Research (5 papers). Peter L. Myers collaborates with scholars based in United States, United Kingdom and Netherlands. Peter L. Myers's co-authors include Dale L. Boger, Christopher B. Chapleo, Daniel D. Comer, Soan Cheng, Christine M. Tarby, John P. Williams, Anthony P. Welbourn, Lynn Helena Caporale, Michael R. Stillings and Malcolm Myers and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Peter L. Myers

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter L. Myers United States 21 841 798 144 130 106 65 1.4k
John C. Hodges United States 23 1.0k 1.2× 1.3k 1.6× 107 0.7× 179 1.4× 104 1.0× 56 2.1k
S. E. Wolkenberg United States 24 1.4k 1.7× 851 1.1× 189 1.3× 232 1.8× 164 1.5× 52 2.2k
Daniele Donati Italy 22 802 1.0× 681 0.9× 212 1.5× 250 1.9× 88 0.8× 118 1.6k
G. F. Lundell United States 13 983 1.2× 767 1.0× 81 0.6× 184 1.4× 200 1.9× 22 1.6k
Serge Halazy France 20 739 0.9× 681 0.9× 79 0.5× 224 1.7× 49 0.5× 70 1.4k
James R. McCarthy United States 37 2.2k 2.6× 1.2k 1.5× 201 1.4× 124 1.0× 144 1.4× 117 3.6k
Cristiano R. W. Guimarães United States 19 670 0.8× 878 1.1× 72 0.5× 116 0.9× 318 3.0× 56 1.8k
Sándor Varga United States 19 992 1.2× 1.0k 1.3× 103 0.7× 83 0.6× 162 1.5× 44 1.9k
Simon F. Campbell United Kingdom 22 791 0.9× 833 1.0× 100 0.7× 123 0.9× 124 1.2× 54 1.9k
Patrick Depreux France 21 795 0.9× 871 1.1× 282 2.0× 144 1.1× 159 1.5× 88 1.7k

Countries citing papers authored by Peter L. Myers

Since Specialization
Citations

This map shows the geographic impact of Peter L. Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter L. Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter L. Myers more than expected).

Fields of papers citing papers by Peter L. Myers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter L. Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter L. Myers. The network helps show where Peter L. Myers may publish in the future.

Co-authorship network of co-authors of Peter L. Myers

This figure shows the co-authorship network connecting the top 25 collaborators of Peter L. Myers. A scholar is included among the top collaborators of Peter L. Myers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter L. Myers. Peter L. Myers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agosti, R., Oliver Findling, Peter L. Myers, et al.. (2023). Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study. Pain and Therapy. 12(2). 575–591. 2 indexed citations
2.
Shen, Yuqiao, Ying Feng, Bing Wang, et al.. (2011). Abstract B64: Structure and preclinical characterization of BMN 673, a potent and orally active PARP inhibitor as an anticancer agent.. Molecular Cancer Therapeutics. 10(11_Supplement). B64–B64. 2 indexed citations
3.
Mignon, Sylvia I., et al.. (2009). Substance Use and Abuse. Lynne Rienner Publishers eBooks. 3 indexed citations
4.
Moree, Wilna J., Ken-ichiro Kataoka, Tatsuki Shiota, et al.. (2008). Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series. Bioorganic & Medicinal Chemistry Letters. 18(6). 1869–1873. 22 indexed citations
5.
Myers, Peter L.. (2005). Book Review: Therapy Culture: Cultivating Vulnerability in an Uncertain Age. Transcultural Psychiatry. 42(4). 676–679.
6.
Shiota, Tatsuki, Ken-ichiro Kataoka, Christine M. Tarby, et al.. (2004). Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(21). 5407–5411. 22 indexed citations
7.
Moree, Wilna J., Ken-ichiro Kataoka, Tatsuki Shiota, et al.. (2004). Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure–activity relationships of diamine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(21). 5413–5416. 33 indexed citations
8.
9.
Myers, Peter L.. (2002). The Management of Identity in Bodegas. Journal of Ethnicity in Substance Abuse. 1(3). 75–92. 5 indexed citations
10.
Myers, Peter L.. (2002). Killing of the Innu. Journal of Ethnicity in Substance Abuse. 1(2). 1–7. 1 indexed citations
11.
Cheng, Soan, Christine M. Tarby, Daniel D. Comer, et al.. (1996). A solution-phase strategy for the synthesis of chemical libraries containing small organic molecules: A universal and dipeptide mimetic template. Bioorganic & Medicinal Chemistry. 4(5). 727–737. 66 indexed citations
12.
Cheng, Soan, Daniel D. Comer, John P. Williams, Peter L. Myers, & Dale L. Boger. (1996). Novel Solution Phase Strategy for the Synthesis of Chemical Libraries Containing Small Organic Molecules. Journal of the American Chemical Society. 118(11). 2567–2573. 135 indexed citations
13.
Luzzio, Michael J., Jeffrey M. Besterman, David L. Emerson, et al.. (1995). Synthesis and Antitumor Activity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I. Journal of Medicinal Chemistry. 38(3). 395–401. 122 indexed citations
14.
Xu, Yao‐Chang, et al.. (1994). DDQ-Induced, Anomeric Specific, and Diastereoselective Benzylic Glycosidation: A Novel Approach to Heterocyclic Anthracycline Antibiotics. The Journal of Organic Chemistry. 59(17). 4868–4874. 14 indexed citations
15.
Myers, Peter L.. (1990). Sources and Configurations of Institutional Denial. Employee Assistance Quarterly. 5(3). 43–54. 4 indexed citations
16.
Chapleo, Christopher B., David C. England, Peter L. Myers, et al.. (1989). Heteroaromatic analogs of the .alpha.2-adrenoreceptor partial agonist clonidine. Journal of Medicinal Chemistry. 32(7). 1627–1630. 15 indexed citations
17.
Harrison, Timothy, Gerald Pattenden, & Peter L. Myers. (1988). Radical cyclisations onto 2(5)-furanone and maleate electrophores leading to spiro- and linear-fused γ-lactone ring systems. Tetrahedron Letters. 29(31). 3869–3872. 15 indexed citations
18.
Chapleo, Christopher B., et al.. (1987). Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 3. Guanidines. Journal of Medicinal Chemistry. 30(5). 951–954. 21 indexed citations
19.
Welbourn, Anthony P., Christopher B. Chapleo, Anthony C. Lane, et al.. (1986). .alpha.-Adrenoreceptor reagents. 4. Resolution of some potent selective prejunctional .alpha.2-adrenoreceptor antagonists. Journal of Medicinal Chemistry. 29(10). 2000–2003. 29 indexed citations
20.
Chapleo, Christopher B., et al.. (1983). .alpha.-Adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic .alpha.2-adrenoreceptor antagonists and potential antidepressants. Journal of Medicinal Chemistry. 26(6). 823–831. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John C. Hodges Breakdown of academic impact, for papers by S. E. Wolkenberg Breakdown of academic impact, for papers by Daniele Donati Breakdown of academic impact, for papers by G. F. Lundell Breakdown of academic impact, for papers by Serge Halazy Breakdown of academic impact, for papers by James R. McCarthy Breakdown of academic impact, for papers by Cristiano R. W. Guimarães Breakdown of academic impact, for papers by Sándor Varga Breakdown of academic impact, for papers by Simon F. Campbell Breakdown of academic impact, for papers by Patrick Depreux
Rankless by CCL
2026